Owens Minor Inc Q3 2024 Earnings Report Preview What To Look For
| SHPCX Fund | USD 13.90 0.03 0.22% |
Slightly above 55% of Health Biotchnology's investor base is interested to short. The analysis of overall sentiment of trading Health Biotchnology Portfolio mutual fund suggests that many investors are impartial at this time. Health Biotchnology's investing sentiment can be driven by a variety of factors including economic data, Health Biotchnology's earnings reports, geopolitical events, and overall market trends.
Health |
Owens Minor Inc is set to release its Q3 2024 earnings on Nov 4, 2024. The consensus estimate for Q3 2024 revenue is 2,680.66 million, and the earnings
Read at gurufocus.com
 |
Health Biotchnology Fundamental Analysis
We analyze Health Biotchnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Biotchnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Biotchnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Health Biotchnology is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Health Biotchnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Health Biotchnology mutual fund to make a market-neutral strategy. Peer analysis of Health Biotchnology could also be used in its relative valuation, which is a method of valuing Health Biotchnology by comparing valuation metrics with similar companies.
Peers
Health Biotchnology Related Equities
| VOLMX | Volumetric Fund | 0.34 | ||||
| TQAAX | T Rowe | 0.32 | ||||
| CPUCX | Aam Select | 0.32 | ||||
| WRLDX | Scharf Global | 0.24 | ||||
| ABVCX | Ab Value | 0.1 | ||||
| TWBIX | Balanced Fund | 0.1 |
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |